Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2006-2007 Formulation (Intramuscular Route)
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 21 Sep 2008 Actual end date (Aug 2007) added as reported by ClinicalTrials.gov.
- 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov.
- 12 Dec 2006 New trial record.